BCSFX | OSMYX | BCSFX / OSMYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 19 years | - |
Gain YTD | 7.913 | -4.935 | -160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 1000 | 50,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.21B | 3.79B | 58% |
Annual Yield % from dividends | 0.01 | 1.08 | 1% |
Returns for 1 year | 19.86 | 2.56 | 776% |
Returns for 3 years | -16.99 | -34.44 | 49% |
Returns for 5 years | 42.07 | -14.96 | -281% |
Returns for 10 years | N/A | 30.19 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQVIX | 19.78 | 0.23 | +1.18% |
T. Rowe Price Integrated US LCV Eq I | |||
FCEUX | 17.49 | 0.11 | +0.63% |
Franklin U.S. Core Equity Advisor | |||
OGEAX | 89.22 | 0.48 | +0.54% |
JPMorgan Equity Index A | |||
BREAX | 31.78 | N/A | N/A |
BlackRock International Dividend Inv A | |||
KCGSX | 20.79 | N/A | N/A |
Knights of Columbus Large Cap Growth S |